ID: ALA2393335

Max Phase: Preclinical

Molecular Formula: C10H9N3O2

Molecular Weight: 203.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNc1ccnc2cc([N+](=O)[O-])ccc12

Standard InChI:  InChI=1S/C10H9N3O2/c1-11-9-4-5-12-10-6-7(13(14)15)2-3-8(9)10/h2-6H,1H3,(H,11,12)

Standard InChI Key:  ILAROVRUDVAMCZ-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.20Molecular Weight (Monoisotopic): 203.0695AlogP: 2.18#Rotatable Bonds: 2
Polar Surface Area: 68.06Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.00CX LogP: 1.54CX LogD: 1.54
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.60Np Likeness Score: -1.34

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source